Merck & Co Inc
Merck & Co Inc를 보는 글로벌 시선
이 종목 직접 발언을 우선한 글로벌 증권사·투자대가의 공개 원문 · RICHMAP 추천 아님
재무 요약
Finnhub /stock/metric · 연간 기준 · 캐시 6h▸ Finnhub /stock/profile2 · 캐시 24h · 모든 수치 API 원값 (RICHMAP 가공·추정 없음)
관련 뉴스
Finnhub /company-news · 최근 14일 · 캐시 30minIOVA Q2 Earnings Beat, Stock Jumps 43% on Strong Amtagvi Uptake
Iovance rises 43% after Q2 results top estimates as Amtagvi sales beat forecasts, boosting revenues and prompting a review of full-year guidance.
원문 보기 ↗ YahooMerck (MRK) Could Be 3% Undervalued On Raised Outlook And Key Drug Approvals
Merck (MRK) is back in focus after a run of product and earnings headlines. Fresh approvals and label expansion efforts for KEYTRUDA and ENFLONSIA now sit alongside a raised 2026 revenue outlook and r…
원문 보기 ↗ YahooU.S. CDC Says As Of August 6, 2,465 Confirmed Measles Cases Were Reported In U.S. In 2026; There Have Been 38 New Measles Outbreaks Reported In 2026, And 94% Of Confirmed Cases Are Outbreak-Associated
https://www.cdc.gov/measles/data-research/index.html
원문 보기 ↗ BenzingaEndometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
Opportunities center on frontline immunotherapy combinations, biomarker and companion diagnostics, AI-enabled pathology, minimally invasive screening, precision therapies for uterine sarcomas, and tel…
원문 보기 ↗ YahooThese New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks
Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, Summit Therapeutics, and more.
원문 보기 ↗ YahooFor Moderna’s Greenlit mRNA Flu Vaccine, Payoff Is a Ways Off
The company says it expects to have mFlusiva ready for the upcoming 2026-2027 flu season, which runs from roughly October to May.
원문 보기 ↗ YahooThis Biotech Dealmaker — Tied To Merck, Travere — Is In A Profit-Taking Zone
Ligand stock landed in a profit-taking zone Thursday on a strong second-quarter report and an earnings guidance hike.
원문 보기 ↗ YahooWhich dow jones stocks are moving on Thursday?
Stay updated with the movement of dow jones stocks in today's session. Discover which dow jones stocks are making waves on Thursday.
원문 보기 ↗ ChartMillRVMD Posts Wider-Than-Anticipated Loss in Q2, Lifts '26 Expense View
Revolution Medicines posts a wider-than-expected loss in Q2 and raises its 2026 expense outlook again as investors weigh higher spending and pipeline progress.
원문 보기 ↗ YahooThursday's session: top gainers and losers in the dow jones index
Curious about the dow jones stocks that are in motion on Thursday? Join us as we explore the top movers within the dow jones index during today's session.
원문 보기 ↗ ChartMillAfter Q2 Earnings, Is Pfizer or Merck the Smarter Dividend Play?
Pfizer carries one of Big Pharma's fattest yields while Merck burns cash on deals to secure its next growth era. Which trade-off actually serves income investors better after both companies reported e…
원문 보기 ↗ YahooWhy This Biotech Dealmaker — Tied To Merck, Travere — Charged Higher
Ligand stock bounded out of a profit-taking zone Thursday on a strong second-quarter report and an earnings guidance hike.
원문 보기 ↗ Yahoo내 성향 트레이더로 도전
주어는 당신의 성향이지 이 종목이 아닙니다. 6시간부터 1년까지 운용기간을 고르면, AI가 기간에 맞는 주기로 가상 매매합니다. 페이지를 닫아도 서버에서 계속 진행됩니다.
트레이더 성향 설정
객관식만 · 주관식 0 · 생성 후 변경 불가
본 페이지는 정보 제공 목적의 종목 정보 색인이며, 투자 권유·자문·중개가 아닙니다. RICHMAP은 증권사·금융투자업자가 아닙니다. 시세·재무·뉴스는 외부 데이터 소스(Finnhub 등)의 정보로 실시간성·정확성을 보증하지 않습니다. 모든 수치는 API 원값으로 RICHMAP의 가공·추정이 없으며, 조회 실패 시 "데이터 없음"으로 명시됩니다. 투자 판단과 그 결과 책임은 본인에게 있으며, 실제 거래는 정식 인가 증권사를 통해 본인 판단하에 진행하시기 바랍니다.